activity
20172022
most citedEmploying latent variable models to improve efficiency in composite endpoint analysis

8 citations · 15 across the 9 of their papers we have counts for

collaborators

19 papers

stat.ME20224 cited

Online error control for platform trials

David S. Robertson, James M. S. Wason, Franz König +2

Platform trials evaluate multiple experimental treatments under a single master protocol, where new treatment arms are added to the trial over time. Given the multiple treatment co…

stat.AP2020

Conditional Power and Friends: The Why and How of (Un)planned, Unblinded Sample Size Recalculations in Confirmatory Trials

Kevin Kunzmann, Michael J. Grayling, Kim M. Lee +3

Adapting the final sample size of a trial to the evidence accruing during the trial is a natural way to address planning uncertainty. Designs with adaptive sample size need to acco…

stat.ME2019

Sample Size Estimation using a Latent Variable Model for Mixed Outcome Co-Primary, Multiple Primary and Composite Endpoints

Martina McMenamin, Jessica K. Barrett, Anna Berglind +1

Mixed outcome endpoints that combine multiple continuous and discrete components to form co-primary, multiple primary or composite endpoints are often employed as primary outcome m…

stat.ME2019

Bayesian design and analysis of external pilot trials for complex interventions

Duncan T. Wilson, James M. S. Wason, Julia Brown +2

External pilot trials of complex interventions are used to help determine if and how a confirmatory trial should be undertaken, providing estimates of parameters such as recruitmen…

stat.ME2019

Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy

Haiyan Zheng, James M. S. Wason

Basket trials have emerged as a new class of efficient approaches in oncology to evaluate a new treatment in several patient subgroups simultaneously. In this paper, we extend the…

stat.CO2019

A web application for the design of multi-arm clinical trials

Michael J Grayling, James MS Wason

Multi-arm designs provide an effective means of evaluating several treatments within the same clinical trial. Given the large number of treatments now available for testing in many…